January 27, 2009

Advertising Pays, Abilify's 2008 Sales Rocket Upwards

Bristol-Myers Squibb today announced its 2008 financials and its atypical antipsychotic Abilify, the object of much TV advertising over the last year, saw its sales hit $2.15 billion, a 30 percent jump over 2007's sales of $1.66 billion. The company has been advertising Abilify on TV both as an add-on treatment for depression (i.e., for use in cases where an anti-depressant alone isn't enough) and for bipolar disorder, the first TV ads ever seen for an antipsychotic. So it's clear that advertising pays.

I've criticized both the ad and the drug in recent months, both in its bipolar version and in its more recent incarnation as an anti-depressant (and in a slightly newer version of the ad). I've noted that the drug is likelier to cause akathisia than it is to successfully treat depression. I've criticized the depression ads for craftily re-branding Abilify as an anti-depressant, when it is actually an antipsychotic. I've slammed the FDA for refusing to comment on BMS's attempt to advertise the drug as an anti-depressant, which in my mind has got to be in violation of the agency's marketing regulations. And I've written about adverse events experienced by children and teens and caused by Abilify. In 2007, I noted that Abilify ads were being pasted to phone booths around Seattle.

BMS is, of course, the same company that in 2007 agreed to pay a $515 million settlement to the feds, much of it to answer allegations that the company had marketed Abilify off-label for use in kids and dementia in the elderly. I guess the big boost in sales in 2008 sort of helps cover that fine.

I'll leave it at that.

Posted by Philip Dawdy at January 27, 2009 11:23 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

To be honest, it's really disturbing that the FDA allows ads like the ones running for Abilify on the basis of such terrible science and the result is a huge growth in sales, but even worse is the destruction in the quality of life of thousands, if not millions, of people. Read www.clinpsyc.blogspot.com today for more on this topic and an analysis of the "science."

Posted by: Sara at January 27, 2009 11:35 AM

I was recently hospitalized for my depression and was asked to take Abilify and initially refused it, but I read up on it (both bad and good) and decided to try it.

I personally am disgusted by this kind of advertising, and didn't want to take any medicine that I saw an ad for.

But... Sine I've been on the Abilify (as an adjunct to my regular meds), I've been feeling so much better. I had a jittery feeling at first, but that's gone away.

I'm concerned about side effects, definitely.
I'm appalled at how big pharma works.
I'm willing to give this med a try, even if it seems naive of me.
I just need to find some way to live and become productive again.

That's my story.

Posted by: Jennifer at January 28, 2009 06:35 AM

Jenniifer, thanks for sharing your story. Do you think there's any chance your "regular meds" may have contributed to your feeling of needing "to find a way to live and become productive again?" I hope your treatment continues to work for you but if things go south again be sure you understand how to get off carefully before continuing to escalate your treatment. There are always two options when meds don't seem to be working, not just one, that is you can reduce or (better yet) eliminate the exisiting meds or add new ones. You may not need to be a patient for the rest of your life.

Posted by: Sara at January 28, 2009 08:55 AM
Post a comment









Remember personal info?






pic1.jpg

Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Search


Recent Entries
$99 Left
$114 To Go
Winter Fundraiser, $134 To Go, Final Day
Ruth Lilly, Eli Lilly Heiress, Prozac Beneficiary Dies At 94
Winter Fundraiser, Final Day, Less Than $200 To Go
UCLA Psychiatrist Criticizes DSM-5
Winter Fundraiser, Barely $200 To Go
Most Popular Posts Of 2009
Winter Fundraiser, Less Than $300 Left, Let's Wrap It Up
Senate Health Care Bill Contains $1.25 Billion Gift To Sen. Stabenow
Travel Day, Comment Approval May Be Intermittent
Winter Fundraiser, Close But Stalled
Senate Health Care Reform Bill Contains Controversial MOTHERS Act, Abortion Study
Adult ADHD And Sleep Problems
Vic Chesnutt Dead At 45, Possible Suicide
Recent Comments

Sara on Advertising Pays, Abilify's 2008 Sales Rocket Upwards

Jennifer on Advertising Pays, Abilify's 2008 Sales Rocket Upwards

Sara on Advertising Pays, Abilify's 2008 Sales Rocket Upwards

Archives
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Powered by
Movable Type 3.2